The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
26564401 |
5 |
Efficient stereoselective synthesis of 2-acetamido-1,2-dideoxyallonojirimycin (DAJNAc) and sp(2)-iminosugar conjugates: Novel hexosaminidase inhibitors with discrimination capabilities between the mature and precursor forms of the enzyme. |
The Barcelona Institute of Science and Technology |
25984755 |
30 |
Pyrimethamine Derivatives: Insight into Binding Mechanism and Improved Enhancement of Mutantß-N-acetylhexosaminidase Activity. |
Sickkids |
18406613 |
10 |
N-Acetylhexosaminidase inhibitory properties of C-1 homologated GlcNAc- and GalNAc-thiazolines. |
The State University of New Jersey |
31487175 |
195 |
Discovery of MK-8719, a Potent O-GlcNAcase Inhibitor as a Potential Treatment for Tauopathies. |
Merck |
30613333 |
37 |
Modification of the Thioglycosyl-Naphthalimides as Potent and Selective Human O-GlcNAcase Inhibitors. |
China Agricultural University |
24900704 |
24 |
Development of Unsymmetrical Dyads As Potent Noncarbohydrate-Based Inhibitors against Human ?-N-Acetyl-d-hexosaminidase. |
East China University of Science and Technology |
14645664 |
35 |
Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D. |
University of Pittsburgh |
18269230 |
87 |
Derivatives of 4-Amino-6-hydroxy-2-mercaptopyrimidine as Novel, Potent, and Selective A3 Adenosine Receptor Antagonists. |
Universita Di Napoli |